HNHiroshi Naganuma

Hiroshi Naganuma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroshi Naganuma has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Jun Matsushima

    Department of Pathology, Saitama Medical University International Medical Center, Saitama 350-1298, Japan

    1 shared publication
  • Michio Shimizu

    Department of Pathology, Saitama Medical University International Medical Center, Saitama 350-1298, Japan

    1 shared publication
  • Naoki Nihei

    Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan

    1 shared publication
  • Naoto Kuroda

    Division of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi 780-8562, Japan

    1 shared publication
  • Satoshi Ota

    Departments of Diagnostic Pathology, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan

    1 shared publication
  • Shiho Watanabe

    Department of Plastic and Reconstructive Surgery, Keio University School of Medicine, Tokyo, Japan

    1 shared publication

Latest Publications

  • Open Access

    Adult Nephroblastoma with Predominant Epithelial Component: A Differential Diagnostic Candidate of Papillary Renal Cell Carcinoma and Metanephric Adenoma—Report of Three Cases

    by Shiho Watanabe, Hiroshi Naganuma, Michio Shimizu, Satoshi Ota, Shin-Ichi Murata, Naoki Nihei, Jun Matsushima, Shuji Mikami, Naoto Kuroda, Yoji Nagashima, et al.

    Although nephroblastoma is the commonest renal tumor of childhood, it is rare in adults. In cases of predominantly epithelial type occurring in adulthood, it might be difficult to distinguish it from papillary renal cell carcinoma and metanephric adenoma. Here, we report three cases of adult epithelial nephroblastoma in 24-, 76-, and 21-year-old females. Histologically, the tumors were composed of papillotubular architectures of small and uniform tumor cells with high nucleocytoplasmic ratio without blastemal element. Immunohistochemically, the tumor cells were positive for WT-1 and CD57 but negative for AMACR, which was helpful to exclude the possibility of papillary renal cell carcinoma. Metanephric adenoma is a benign tumor, which can be distinguished by the observation of the cellular atypism and growth pattern. However, nephroblastoma with predominant epithelial element mimics the malignant counterpart of metanephric adenoma, that is, “metanephric adenocarcinoma.”